|
Market Closed -
Nasdaq
01:30:00 24/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 9.990 USD | 0.00% |
|
+3.95% | +62.44% |
| 14/08 | ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026 | |
| 14/08 | ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 9.07Cr | - | - | - | - | - |
| 1,02600Cr | |||||
| 65TCr | - | ||||
| 47TCr | |||||
| 35TCr | |||||
| 27TCr |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
